193 related articles for article (PubMed ID: 26518061)
1. Hemodynamic safety and efficacy of ferumoxytol as an intravenous contrast agents in pediatric patients and young adults.
Ning P; Zucker EJ; Wong P; Vasanawala SS
Magn Reson Imaging; 2016 Feb; 34(2):152-8. PubMed ID: 26518061
[TBL] [Abstract][Full Text] [Related]
2. Ferumoxytol as an off-label contrast agent in body 3T MR angiography: a pilot study in children.
Ruangwattanapaisarn N; Hsiao A; Vasanawala SS
Pediatr Radiol; 2015 Jun; 45(6):831-9. PubMed ID: 25427433
[TBL] [Abstract][Full Text] [Related]
3. Ferumoxytol use as an intravenous contrast agent for magnetic resonance angiography.
Stabi KL; Bendz LM
Ann Pharmacother; 2011 Dec; 45(12):1571-5. PubMed ID: 22045905
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive motion-compensated highly accelerated 4D flow MRI with ferumoxytol enhancement for pediatric congenital heart disease.
Cheng JY; Hanneman K; Zhang T; Alley MT; Lai P; Tamir JI; Uecker M; Pauly JM; Lustig M; Vasanawala SS
J Magn Reson Imaging; 2016 Jun; 43(6):1355-68. PubMed ID: 26646061
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of ferumoxytol-enhanced neonatal and young infant cardiac MRI without general anesthesia.
Lai LM; Cheng JY; Alley MT; Zhang T; Lustig M; Vasanawala SS
J Magn Reson Imaging; 2017 May; 45(5):1407-1418. PubMed ID: 27678106
[TBL] [Abstract][Full Text] [Related]
6. Safety Report of Ferumoxytol for Magnetic Resonance Imaging in Children and Young Adults.
Muehe AM; Feng D; von Eyben R; Luna-Fineman S; Link MP; Muthig T; Huddleston AE; Neuwelt EA; Daldrup-Link HE
Invest Radiol; 2016 Apr; 51(4):221-227. PubMed ID: 26656202
[TBL] [Abstract][Full Text] [Related]
7. Safety of ferumoxytol in children undergoing cardiac MRI under general anaesthesia.
Wise-Faberowski L; Velasquez N; Chan F; Vasanawala S; McElhinney DB; Ramamoorthy C
Cardiol Young; 2018 Jul; 28(7):916-921. PubMed ID: 29848399
[TBL] [Abstract][Full Text] [Related]
8. Brand ferumoxytol vs. generic ferumoxytol comparison across two dosing regimens: a cardiac MRI image quality study.
Dasi A; Kring DN; Selvaraj B; Morgan P; Gerity C; Morgan EE; Krishnamurthy R; Krishnamurthy R
Pediatr Radiol; 2023 Dec; 53(13):2622-2632. PubMed ID: 37837456
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced magnetic resonance venography in pediatric patients with chronic kidney disease: initial experience with ferumoxytol.
Luhar A; Khan S; Finn JP; Ghahremani S; Griggs R; Zaritsky J; Salusky I; Hall TR
Pediatr Radiol; 2016 Aug; 46(9):1332-40. PubMed ID: 27059620
[TBL] [Abstract][Full Text] [Related]
10. Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging.
Nguyen KL; Park EA; Yoshida T; Hu P; Finn JP
J Cardiovasc Magn Reson; 2017 Dec; 19(1):106. PubMed ID: 29284494
[TBL] [Abstract][Full Text] [Related]
11. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
Neuwelt EA; Várallyay CG; Manninger S; Solymosi D; Haluska M; Hunt MA; Nesbit G; Stevens A; Jerosch-Herold M; Jacobs PM; Hoffman JM
Neurosurgery; 2007 Apr; 60(4):601-11; discussion 611-2. PubMed ID: 17415196
[TBL] [Abstract][Full Text] [Related]
12. Multicenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRI.
Nguyen KL; Yoshida T; Kathuria-Prakash N; Zaki IH; Varallyay CG; Semple SI; Saouaf R; Rigsby CK; Stoumpos S; Whitehead KK; Griffin LM; Saloner D; Hope MD; Prince MR; Fogel MA; Schiebler ML; Roditi GH; Radjenovic A; Newby DE; Neuwelt EA; Bashir MR; Hu P; Finn JP
Radiology; 2019 Dec; 293(3):554-564. PubMed ID: 31638489
[TBL] [Abstract][Full Text] [Related]
13. Lower extremity deep venous thrombosis: evaluation with ferumoxytol-enhanced MR imaging and dual-contrast mechanism--preliminary experience.
Li W; Salanitri J; Tutton S; Dunkle EE; Schneider JR; Caprini JA; Pierchala LN; Jacobs PM; Edelman RR
Radiology; 2007 Mar; 242(3):873-81. PubMed ID: 17325072
[TBL] [Abstract][Full Text] [Related]
14. Ferumoxytol as an intraprostatic MR contrast agent for lymph node mapping of the prostate: a feasibility study in non-human primates.
Sankineni S; Smedley J; Bernardo M; Brown AM; Johnson L; Muller B; Griffiths GL; Kobayashi H; Rais-Bahrami S; Pinto PA; Wood BJ; Keele B; Choyke PL; Turkbey B
Acta Radiol; 2016 Nov; 57(11):1396-1401. PubMed ID: 26013022
[TBL] [Abstract][Full Text] [Related]
15. Can Ferumoxytol be Used as a Contrast Agent to Differentiate Between Acute and Chronic Inflammatory Kidney Disease?: Feasibility Study in a Rat Model.
Budjan J; Neudecker S; Schock-Kusch D; Kraenzlin B; Schoenberg SO; Michaely HJ; Attenberger UI
Invest Radiol; 2016 Feb; 51(2):100-5. PubMed ID: 26352750
[TBL] [Abstract][Full Text] [Related]
16. Macrophage Imaging of Cerebral Aneurysms with Ferumoxytol: an Exploratory Study in an Animal Model and in Patients.
Aoki T; Saito M; Koseki H; Tsuji K; Tsuji A; Murata K; Kasuya H; Morita A; Narumiya S; Nozaki K;
J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2055-2064. PubMed ID: 28774792
[TBL] [Abstract][Full Text] [Related]
17. MRI with ferumoxytol: A single center experience of safety across the age spectrum.
Nguyen KL; Yoshida T; Han F; Ayad I; Reemtsen BL; Salusky IB; Satou GM; Hu P; Finn JP
J Magn Reson Imaging; 2017 Mar; 45(3):804-812. PubMed ID: 27480885
[TBL] [Abstract][Full Text] [Related]
18. Brain Iron Assessment after Ferumoxytol-enhanced MRI in Children and Young Adults with Arteriovenous Malformations: A Case-Control Study.
Iv M; Ng NN; Nair S; Zhang Y; Lavezo J; Cheshier SH; Holdsworth SJ; Moseley ME; Rosenberg J; Grant GA; Yeom KW
Radiology; 2020 Nov; 297(2):438-446. PubMed ID: 32930651
[TBL] [Abstract][Full Text] [Related]
19. Safety of Off-Label Use of Ferumoxtyol as a Contrast Agent for MRI: A Systematic Review and Meta-Analysis of Adverse Events.
Ahmad F; Treanor L; McGrath TA; Walker D; McInnes MDF; Schieda N
J Magn Reson Imaging; 2021 Mar; 53(3):840-858. PubMed ID: 33098154
[TBL] [Abstract][Full Text] [Related]
20. Incidental ferumoxytol artifacts in clinical brain MR imaging.
Bowser BA; Campeau NG; Carr CM; Diehn FE; McDonald JS; Miller GM; Kaufmann TJ
Neuroradiology; 2016 Nov; 58(11):1087-1091. PubMed ID: 27704163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
